CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?
The Motley Fool compared CME Group and Morningstar, citing CME’s 2025 net margin and year-end debt relative to equity. It also noted Morningstar’s 2016 acquisition of PitchBook and its completion of the roughly $363 million CRSP purchase on Feb. 2, 2026.
Why it matters — The item highlights Morningstar’s acquisitions, including its recent purchase of index provider CRSP, in a comparison with CME Group.